Cholangiocarcinoma (CAA) and other liver cancer subtypes often develop in damaged
organs. Physiologic agents or extrinsic factors like toxins can induce cell death in such …

Cholangiocarcinoma (CCA) is a highly heterogeneous and aggressive malignancy of the
bile ducts with a poor prognosis and high mortality rate. Effective targeted therapy and …

Precision immunotherapy, driven by genomic and bioinformatic advancements, has
emerged as a promising and viable approach to combat cancer. Targeting neoantigens …

Background. Recent years have witnessed the advent of molecular profiling for intrahepatic
cholangiocarcinoma (iCCA), and new techniques have led to the identification of several …

Colorectal cancer (CRC) ranks as the third most commonly diagnosed cancer and the
second leading cause of cancer-related deaths worldwide. Studies have shown that CRC …